- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-3138
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeted Therapies for Melanoma Brain Metastases ; volume:19 ; number:4 ; day:3 ; month:4 ; year:2017 ; pages:1-13 ; date:4.2017
Current treatment options in neurology ; 19, Heft 4 (3.4.2017), 1-13, 4.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Bergmeister-Berghoff, Anna Sophie
- Contributor
- DOI
-
10.1007/s11940-017-0449-2
- URN
-
urn:nbn:de:1111-201704279741
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bergmeister-Berghoff, Anna Sophie
- Preusser, Matthias
- SpringerLink (Online service)
Other Objects (12)
Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations—Chances and Challenges
Anti-angiogenic therapies in brain metastases
Factors associated with hemorrhage of melanoma brain metastases after stereotactic radiosurgery in the era of targeted/immune checkpoint inhibitor therapies
Decoding molecular programs in melanoma brain metastases
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Management of Brain Metastases: A Review of Novel Therapies
Advances in Targeted Therapies for Pediatric Brain Tumors
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies
Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy
Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations—Chances and Challenges
Anti-angiogenic therapies in brain metastases
Factors associated with hemorrhage of melanoma brain metastases after stereotactic radiosurgery in the era of targeted/immune checkpoint inhibitor therapies
Decoding molecular programs in melanoma brain metastases
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Management of Brain Metastases: A Review of Novel Therapies
Advances in Targeted Therapies for Pediatric Brain Tumors
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies
Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy
Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations—Chances and Challenges
Anti-angiogenic therapies in brain metastases
Factors associated with hemorrhage of melanoma brain metastases after stereotactic radiosurgery in the era of targeted/immune checkpoint inhibitor therapies
Decoding molecular programs in melanoma brain metastases
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Management of Brain Metastases: A Review of Novel Therapies
Advances in Targeted Therapies for Pediatric Brain Tumors
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies